Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives

Pharmacology and Therapeutics

Volumn 131, Issue 3, 2011, Pages 309-329

  Mercorelli, Beatrice ^a   Lembo, David ^b   Palù, Giorgio ^a   Loregian, Arianna ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Antiviral therapy; Gene expression; Human cytomegalovirus; Novel antiviral strategies; Virus attachment; Virus entry

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACICLOVIR; ANTIVIRUS AGENT; ARTESUNATE; BAICALEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CF 102; CIDOFOVIR; CPG OLIGODEOXYNUCLEOTIDE; CURDLAN; ENFUVIRTIDE; FOMIVIRSEN; FOSCARNET; FOSCARNET SODIUM; FUCOIDIN; GANCICLOVIR; GELDANAMYCIN; HUMAN MONOCLONAL ANTIBODY; HYPERIMMUNE GLOBULIN; LACTOFERRIN; PROBENECID; RESVERATROL; SB 105; SB105 A10; SORAFENIB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR; VALACYTE; VALGANCICLOVIR; WC 5; WORTMANNIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTHRALGIA; ARTHRITIS; ARTICLE; ASEPTIC MENINGITIS; CARCINOGENESIS; CONGENITAL INFECTION; CREATININE BLOOD LEVEL; CROSS RESISTANCE; CYTOMEGALOVIRUS INFECTION; CYTOMEGALOVIRUS RETINITIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; ELECTROLYTE DISTURBANCE; EYE INFLAMMATION; GENE EXPRESSION; GENE MUTATION; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION PREVENTION; LEUKOPENIA; MYOCARDITIS; NATURAL KILLER CELL; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; PASSIVE IMMUNIZATION; PNEUMONIA; POPULATION DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTIVE TOXICITY; SANITATION; SEXUAL TRANSMISSION; TERATOGENICITY; THROMBOCYTOPENIA; ULCERATIVE COLITIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 79960122975     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.04.007     Document Type: Review

References (287)

1. U. Adhikari, C.G. Mateu, K. Chattopadhyay, C.A. Pujol, E.B. Damonte, and B. Ray Structure and antiviral activity of sulfated fucans from Stoechospermum marginatum Phytochemistry 67 2006 2474 2482 (Pubitemid 44604489)
2. S.P. Adler, and G. Nigro Findings and conclusions from CMV hyperimmune globulin treatment trials J Clin Virol 46 Suppl 4 2009 S54 S57
3. P. Aduma, M.C. Connelly, R.V. Srinivas, and A. Fridland Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates Mol Pharmacol 47 1995 816 822
4. S.M. Akula, D.J. Hurley, R.L. Wixon, C. Wang, and C.C. Chase Effect of genistein on replication of bovine herpesvirus type 1 Am J Vet Res 63 2002 1124 1128 (Pubitemid 35276896)
5. M. Amoros, C.M. Simoes, L. Girre, F. Sauvager, and M. Cormier Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis J Nat Prod 55 1992 1732 1740 (Pubitemid 23023259)
6. J.H. Andersen, S.A. Osbakk, L.H. Vorland, T. Traavik, and T.J. Gutteberg Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts Antiviral Res 51 2001 141 149 (Pubitemid 32592502)
7. K.P. Anderson, M.C. Fox, V. Brown-Driver, M.J. Martin, and R.F. Azad Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA Antimicrob Agents Chemother 40 1996 2004 2011 (Pubitemid 26296237)
8. G. Andrei, R. Snoeck, D. Schols, P. Goubau, J. Desmyter, and E. De Clercq Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus Eur J Clin Microbiol Infect Dis 10 1991 1026 1033
9. V.P. Androutsopoulos, A. Papakyriakou, D. Vourloumis, A.M. Tsatsakis, and D.A. Spandidos Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes Pharmacol Ther 126 2010 9 20
10. A. Angulo, and P. Ghazal Regulation of human cytomegalovirus by retinoic acid Scand J Infect Dis Suppl 99 1995 113 115
11. A.A. Ashkar, S. Bauer, W.J. Mitchell, J. Vieira, and K.L. Rosenthal Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2 J Virol 77 2003 8948 8956 (Pubitemid 36936104)
12. J. Asmar, L. Wiebusch, M. Truss, and C. Hagemeier The putative zinc finger of the human cytomegalovirus IE2 86-kilodalton protein is dispensable for DNA binding and autorepression, thereby demarcating a concise core domain in the C terminus of the protein J Virol 78 2004 11853 11864 (Pubitemid 39390772)
13. S.-P.A. Atreides, C. Wilkins, C.O. Ekworomadu, J.J. Docherty, and R.D. Dix Does resveratrol exhibit antiviral properties against human cytomegalovirus replication? Invest Ophthalmol Vis Sci 43 2002 E-Abstract 4325
14. R.F. Azad, V.B. Driver, K. Tanaka, R.M. Crooke, and K.P. Anderson Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region Antimicrob Agents Chemother 37 1993 1945 1954 (Pubitemid 23265557)
15. A.M. Azarova, R.K. Lin, Y.C. Tsai, L.F. Liu, C.P. Lin, and Y.L. Lyu Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: implications in infant leukemia Biochem Biophys Res Commun 399 2010 66 71
16. M. Baba, R. Snoeck, R. Pauwels, and E. de Clercq Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus Antimicrob Agents Chemother 32 1988 1742 1745 (Pubitemid 18267628)
17. M. Baba, E. De Clercq, D. Schols, R. Pauwels, R. Snoeck, and C. Van Boeckel Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity J Infect Dis 161 1990 208 213 (Pubitemid 20056648)
18. F. Baldanti, E. Silini, A. Sarasini, C.L. Talarico, S.C. Stanat, and K.K. Biron A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate J Virol 69 1995 796 800
19. F. Baldanti, L. Simoncini, C.L. Talarico, A. Sarasini, K.K. Biron, and G. Gerna Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient AIDS 12 1998 816 818 (Pubitemid 28190707)
20. S. Barjesteh van Waalwijk van Doorn-Khosrovani, J. Janssen, L.M. Maas, R.W. Godschalk, J.G. Nijhuis, and F.J. van Schooten Dietary flavonoids induce MLL translocations in primary human CD34+ cells Carcinogenesis 28 2007 1703 1709 (Pubitemid 47289032)
21. M.I. Barrasa, N.Y. Harel, and J.C. Alwine The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early protein IE2/IEP86 affects temporal viral gene expression J Virol 79 2005 1428 1437 (Pubitemid 40459090)
22. W. Basha, R. Kitagawa, M. Uhara, H. Imazu, K. Uechi, and J. Tanaka Geldanamycin, a potent and specific inhibitor of Hsp90, inhibits gene expression and replication of human cytomegalovirus Antivir Chem Chemother 16 2005 135 146 (Pubitemid 41529733)
23. J.A. Baur, and D. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506 (Pubitemid 44136961)
24. R.D. Baynes, and W.R. Bezwoda Lactoferrin and the inflammatory response Adv Exp Med Biol 357 1994 133 141
25. J.T. Bechtel, and T. Shenk Human cytomegalovirus UL47 tegument protein functions after entry and before immediate-early gene expression J Virol 76 2002 1043 1050 (Pubitemid 34066408)
26. L. Beljaars, B.W. van der Strate, H.I. Bakker, C. Reker-Smit, A.M. van Loenen-Weemaes, and F.C. Wiegmans Inhibition of citomegalovirus infection by lactoferrin in vitro and in vivo Antiviral Res 63 2004 197 208 (Pubitemid 39286757)
27. N. Bonaros, B. Mayer, T. Schachner, G. Laufer, and A. Kocher CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis Clin Transplant 22 2008 89 97 (Pubitemid 351150008)
28. D.F. Bratcher, N. Bourne, F.J. Bravo, M.R. Schleiss, M. Slaoui, and M.G. Myers Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs J Infect Dis 172 1995 944 950
29. W. Britt Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease Curr Top Microbiol Immunol 325 2008 417 470
30. L.A. Bryant, P. Mixon, M. Davidson, A.J. Bannister, T. Kouzarides, and J.H. Sinclair The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF J Virol 74 2000 7230 7237 (Pubitemid 30613070)
31. H.C. Buyck, P.D. Griffiths, and V.C. Emery Human cytomegalovirus (HCMV). Replication kinetics in stem cell transplant recipients following anti-HCMV therapy J Clin Virol 49 2010 32 36
32. M.J. Cannon, D.S. Schmid, and T.B. Hyde Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection Rev Med Virol 20 2010 202 213
33. J.P. Castillo, and T.F. Kowalik Human cytomegalovirus immediate early proteins and cell growth control Gene 290 2002 19 34 (Pubitemid 34615906)
34. R. Caswell, C. Hagemeier, C.J. Chiou, G. Hayward, T. Kouzarides, and J. Sinclair The human cytomegalovirus 86 K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation J Gen Virol 74 1993 2691 2698 (Pubitemid 24020662)
35. T. Cha, E. Tom, G. Kemble, G. Duke, E. Mocarski, and R. Spaete Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains J Virol 70 1996 78 83 (Pubitemid 126508771)
36. G. Chan, M.T. Nogalski, and A.D. Yurochko Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility Proc Natl Acad Sci U S A 106 2009 22369 22374
37. S.H. Chao, J.N. Harada, F. Hyndman, X. Gao, C.G. Nelson, and S.K. Chanda PDX1, a cellular homeoprotein, binds to and regulates the activity of human cytomegalovirus immediate early promoter J Biol Chem 279 2004 16111 16120 (Pubitemid 38509302)
38. K. Chattopadhyay, C.G. Mateu, P. Mandal, C.A. Pujol, E.B. Damonte, and B. Ray Galactan sulfate of Grateloupia indica: isolation, structural features and antiviral activity Phytochemistry 68 2007 2428 2435
39. K. Chattopadhyay, T. Ghosh, C.A. Pujol, M.J. Carlucci, E.B. Damonte, and B. Ray Polysaccharides from Gracilaria corticata: sulfation, chemical characterization and anti-HSV activities Int J Biol Macromol 43 2008 346 351
40. J. Chen, and M.F. Stinski Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression J Virol 76 2002 4873 4885 (Pubitemid 34441693)
41. C.J. Chen, S.L. Raung, S.L. Liao, and S.Y. Chen Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia Biochem Pharmacol 67 2004 957 965
42. L.C. Chiang, W. Chiang, M.C. Liu, and C.C. Lin In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids J Antimicrob Chemother 52 2003 194 198 (Pubitemid 36986878)
43. P. Chrisp, and S.P. Clissold Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis Drugs 41 1991 104 129 (Pubitemid 21920729)
44. P. Cinque, R. Marenzi, and D. Ceresa Cytomegalovirus infections of the nervous system Intervirology 40 1997 85 97 (Pubitemid 28021603)
45. C.S. Cobbs, L. Soroceanu, S. Denham, W. Zhang, W.J. Britt, and R. Pieper Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness J Neurooncol 85 2007 271 280 (Pubitemid 350142516)
46. A.M. Colberg-Poley Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci Intervirology 39 1996 350 360 (Pubitemid 27174138)
47. T. Compton, R.R. Nepomuceno, and D.M. Nowlin Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface Virology 191 1992 387 395
48. T. Compton, D.M. Nowlin, and N.R. Cooper Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate Virology 193 1993 834 841
49. P. Cos, L. Maes, A. Vlietinck, and L. Pieters Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection-an update (1998-2007) Planta Med 74 2008 1323 1337
50. C. Cuevas-Bennett, and T. Shenk Dynamic histone H3 acetylation and methylation at human cytomegalovirus promoters during replication in fibroblasts J Virol 82 2008 9525 9536
51. X. Cui, M.P. Meza, S.P. Adler, and M.A. McVoy Human immune sera contain high titers of antibodies that block cytomegalovirus entry into epithelial cells but are induced at low titers by CMV vaccines Vaccine 26 2008 5760 5766
52. T.P. Cushnie, and A.J. Lamb Antimicrobial activity of flavonoids Int J Antimicrob Agents 26 2005 343 356 (Pubitemid 41483464)
53. R.S. Cvetkovic, and K. Wellington Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients Drugs 65 2005 859 878 (Pubitemid 40598096)
54. W.M. Dankner, J.A. McCutchan, D.D. Richman, K. Hirata, and S.A. Spector Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization J Infect Dis 161 1990 31 36 (Pubitemid 20021853)
55. E. De Clercq, and A. Holy Acyclic nucleoside phosphonates: a key class of antiviral drugs Nat Rev Drug Discov 4 2005 928 940 (Pubitemid 41637695)
56. H. de Martimprey, C. Vauthier, C. Malvy, and P. Couvreur Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA Eur J Pharm Biopharm 71 2009 490 504
57. J.J. Docherty, M.M. Fu, B.S. Stiffler, R.J. Limperos, C.M. Pokabla, and A.L. DeLucia Resveratrol inhibition of herpes simplex virus replication Antiviral Res 43 1999 145 155 (Pubitemid 29457437)
58. J.J. Docherty, J.S. Smith, M.M. Fu, T. Stoner, and T. Booth Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice Antiviral Res 61 2004 19 26 (Pubitemid 37508526)
59. J.J. Docherty, M.M. Fu, J.M. Hah, T.J. Sweet, S.A. Faith, and T. Booth Effect of resveratrol on herpes simplex virus vaginal infection in the mouse Antiviral Res 67 2005 155 162 (Pubitemid 41254199)
60. J.J. Docherty, T.J. Sweet, E. Bailey, S.A. Faith, and T. Booth Resveratrol inhibition of varicella-zoster virus replication in vitro Antiviral Res 72 2006 171 177 (Pubitemid 44708309)
61. A. Dolan, C. Cunningham, R.D. Hector, A.F. Hassan-Walker, L. Lee, and C. Addison Genetic content of wild-type human cytomegalovirus J Gen Virol 85 2004 1301 1312 (Pubitemid 38659794)
62. S.C. Dollard, S.D. Grosse, and D.S. Ross New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection Rev Med Virol 17 2007 355 363 (Pubitemid 47425872)
63. M. Donalisio, M. Rusnati, A. Civra, A. Bugatti, D. Allemand, and G. Pirri Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses Antimicrob Agents Chemother 54 2010 4290 4299
64. L. Dong, I. Mori, M.J. Hossain, B. Liu, and Y. Kimura An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response J Gen Virol 84 2003 1623 1628 (Pubitemid 36675534)
65. B.H. Dvorchik, and J.K. Marquis Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted against human cytomegalovirus, after intravitreal injection of escalating single doses in the rabbit Drug Metab Dispos 28 2000 1255 1261
66. T. Efferth, M. Marschall, X. Wang, S.M. Huong, I. Hauber, and A. Olbrich Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses J Mol Med 80 2002 233 242 (Pubitemid 34439295)
67. E.P. English, R.S. Chumanov, S.H. Gellman, and T. Compton Rational development of beta-peptide inhibitors of human cytomegalovirus entry J Biol Chem 281 2005 2661 2667
68. A. Erice, S. Chou, K.K. Biron, S.C. Stanat, H.H. Balfour Jr., and M.C. Jordan Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients N Engl J Med 320 1989 289 293 (Pubitemid 19045553)
69. J.D. Esko, and U. Lindahl Molecular diversity of heparan sulfate J Clin Invest 108 2001 169 173 (Pubitemid 32656238)
70. D.L. Evers, X. Wang, S.M. Huong, D.Y. Huang, and E.S. Huang 3,4′,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling Antiviral Res 63 2004 85 95 (Pubitemid 39061773)
71. D.L. Evers, C.F. Chao, X. Wang, Z. Zhang, S.M. Huong, and E.S. Huang Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action Antiviral Res 68 2005 124 134 (Pubitemid 41612456)
72. A. Farina, C. Ferranti, and C. Marra An improved synthesis of resveratrol Nat Prod Res 20 2006 247 252 (Pubitemid 43102143)
73. E. Fattal, and A. Bochot State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers Int J Pharm 364 2008 237 248
74. D. Faulds, and R.C. Heel Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections Drugs 39 1990 597 638
75. A.L. Feire, H. Koss, and T. Compton Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain Proc Natl Acad Sci U S A 101 2004 15470 15475 (Pubitemid 39441565)
76. A.L. Feire, R.M. Roy, K. Manley, and T. Compton The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry J Virol 84 2010 10026 10037
77. L.R. Ferguson, A.L. Tatham, Z. Lin, and W.A. Denny Epigenetic regulation of gene expression as an anticancer drug target Curr Cancer Drug Targets 11 2011 199 212
78. C. Flexner, P.A. Barditch-Crovo, D.M. Kornhauser, H. Farzadegan, L.J. Nerhood, and R.E. Chaisson Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate Antimicrob Agents Chemother 35 1991 2544 2550
79. J.V. Formica, and W. Regelson Review of the biology of quercetin and related bioflavonoids Food Chem Toxicol 33 1995 1061 1080 (Pubitemid 26009773)
80. M. Friedman Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas Mol Nutr Food Res 51 2007 116 134 (Pubitemid 46144767)
81. Y. Fukui, K. Shindoh, Y. Yamamoto, S. Koyano, I. Kosugi, and T. Yamaguchi Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay Antimicrob Agents Chemother 52 2008 2420 2427 (Pubitemid 351915671)
82. A. Funaro, G. Gribaudo, A. Luganini, E. Ortolan, N. Lo Buono, and E. Licenzi Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells BMC Biotechnol 8 2008 85
83. M.K. Gandhi, and R. Khanna Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments Lancet Infect Dis 4 2004 725 738 (Pubitemid 39574344)
84. J.M. Gawn, and R.F. Greaves Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression J Virol 76 2002 4441 4455 (Pubitemid 34309581)
85. G. Gerna, F. Baldanti, and M.G. Revello Pathogenesis of human cytomegalovirus infection and cellular targets Hum Immunol 65 2004 381 386 (Pubitemid 38686760)
86. G. Gerna, E. Percivalle, D. Lilleri, L. Lozza, C. Fornaia, and G. Hahn Dendritic cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8p T cells J Gen Virol 86 2005 275 284 (Pubitemid 40227938)
87. P. Ghosh, U. Adhikari, P. Ghosal, C.A. Pujol, M.J. Carlucci, and E.B. Damonte In vitro anti-herpetic activity of sulfated polysaccharide fractions from Caulerpa racemosa Phytochemistry 65 2004 3151 3157 (Pubitemid 39487097)
88. T. Ghosh, K. Chattopadhyay, M. Marschall, P. Karmakar, P. Mandal, and B. Ray Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation Glycobiology 19 2009 2 15
89. C. Gilbert, and G. Boivin Human cytomegalovirus resistance to antiviral drugs Antimicrob Agents Chemother 49 2005 873 883 (Pubitemid 40327699)
90. M. Gordon, M. Guralnik, Y. Kaneko, T. Mimura, M. Baker, and W. Lang A phase I study of curdlan sulfate-an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes J Med 25 1994 163 180 (Pubitemid 24282283)
91. M. Gordon, S. Deeks, C. De Marzo, J. Goodgame, M. Guralnik, and W. Lang Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity J Med 28 1997 108 128 (Pubitemid 27306338)
92. B. Gorsi, and S.E. Stringer Tinkering with heparan sulfate sulfation to steer development Trends Cell Biol 4 2007 173 177 (Pubitemid 46507809)
93. B.P. Griffith, J.T. Lavallee, T.A. Jennings, and G.D. Hsiung Transmission of maternal cytomegalovirus-specific immunity in the guinea pig Clin Immunol Immunopathol 35 1985 169 181 (Pubitemid 15013432)
94. L.R. Grillone, and R. Lanz Fomivirsen Drugs Today 37 2001 245 255 (Pubitemid 32506283)
95. M. Grover, O. Giouzeppos, R.D. Schnagl, and J.T. May Effect of human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus Acta Paediatr 86 1997 315 316 (Pubitemid 27135280)
96. C. Hagemeier, R. Caswell, G. Hayhurst, J. Sinclair, and T. Kouzarides Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein EMBO J 13 1994 2897 2903 (Pubitemid 24191700)
97. G. Hahn, M.G. Revello, M. Patrone, E. Percivalle, G. Campanili, and A. Saracini Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes J Virol 78 2004 10023 10033 (Pubitemid 39187120)
98. M.C. Harmsen, P.J. Swart, M.P. de Béthune, R. Pauwels, E. De Clercq, and T.H. The Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro J Infect Dis 172 1995 380 388
99. S.M. Harris, B. Bullock, E. Westgard, H. Zhu, R.M. Stenberg, and J.A. Kerry Functional properties of the human cytomegalovirus IE86 protein required for transcriptional regulation and virus replication J Virol 84 2010 8839 8848
100. K. Hayashi, T. Hayashi, and I. Kojima A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti human immunodeficiency virus activities AIDS Res Hum Retroviruses 12 1996 1463 1471 (Pubitemid 26341539)
101. T. Hayashi, K. Hayashi, M. Maeda, and I. Kojima Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis J Nat Prod 59 1996 83 87 (Pubitemid 27074392)
102. K. Hayashi, T. Hayashi, H. Otsuka, and Y. Takeda Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir J Antimicrob Chemother 39 1997 821 824 (Pubitemid 27296426)
103. K. Hayashi, K. Minoda, Y. Nagaoka, T. Hayashi, and S. Uesato Antiviral activity of berberine and related compounds against human cytomegalovirus Bioorg Med Chem Lett 17 2007 1562 1564
104. K.E. Heim, A.R. Tagliaferro, and D.J. Bobilya Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships J Nutr Biochem 13 2002 572 584 (Pubitemid 35246546)
105. A. Heredia, C. Davis, and R. Redfield Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol J Acquir Immune Defic Syndr 25 2000 246 255 (Pubitemid 32010127)
106. T.T. Hien, K. Arnold, H. Vinh, B.M. Cuong, N.H. Phu, and T.T. Chau Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria Trans R Soc Trop Med Hyg 86 1992 582 583 (Pubitemid 23012892)
107. T.T. Hien, N.H. Phu, N.T. Mai, T.T. Chau, T.T. Trang, and P.P. Loc An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria Trans R Soc Trop Med Hyg 86 1992 584 585 (Pubitemid 23012893)
108. T. Hoshino, T. Hayashi, K. Hayashi, J. Hamada, J.B. Lee, and U. Sankawa An antivirally active sulfated polysaccharide from Sargassum horneri (TURNER) C. AGARDH Biol Pharm Bull 21 1998 730 734 (Pubitemid 28374448)
109. H.C. Huang, L.M. Hsieh, H.W. Chen, Y.S. Lin, and J.S. Chen Effects of baicalein and esculetin on transduction signals and growth factors expression in T-lymphoid leukemia cells Eur J Pharmacol 268 1994 73 78
110. Y. Huang, S.Y. Tsang, X. Yao, and Z.Y. Chen Biological properties of baicalein in cardiovascular system Curr Drug Targets Cardiovasc Haematol Disord 5 2005 177 184 (Pubitemid 40645490)
111. M.T. Huber, and T. Compton The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex J Virol 72 1998 8191 8197 (Pubitemid 28421815)
112. G.W. Hunninghake, M.M. Monick, B. Liu, and M.F. Stinski The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements J Virol 63 1989 3026 3033 (Pubitemid 19156022)
113. J. Hwang, and R.F. Kalejta Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp 71 protein in human cytomegalovirus-infected cells Virology 367 2007 334 338 (Pubitemid 47494530)
114. J. Hwang, and R.F. Kalejta Human cytomegalovirus protein pp 71 induces Daxx SUMOylation J Virol 83 2009 6591 6598
115. J.M. Irache, M. Merodio, A. Arnedo, M.A. Camapanero, M. Mirshahi, and S. Espuelas Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs Mini Rev Med Chem 5 2005 293 305 (Pubitemid 40331045)
116. M.K. Isaacson, and T. Compton Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress J Virol 83 2009 3891 3903
117. M.K. Isaacson, A.L. Feire, and T. Compton Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling J Virol 81 2007 6241 6247 (Pubitemid 46878030)
118. A.M. Ishov, R.M. Stenberg, and G.G. Maul Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment J Cell Biol 138 1997 5 16 (Pubitemid 27337448)
119. H. Isomura, and M.F. Stinski The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection J Virol 77 2003 3602 3614 (Pubitemid 36297280)
120. H. Isomura, T. Tsurumi, and M.F. Stinski Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication J Virol 78 2004 12788 12799 (Pubitemid 39507787)
121. H. Isomura, M.F. Stinski, A. Kudoh, T. Daikoku, N. Shirata, and T. Tsurumi Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication J Virol 79 2005 9597 9607 (Pubitemid 41022303)
122. H. Isomura, M.F. Stinski, A. Kudoh, S. Nakayama, T. Murata, and Y. Sato A cis element between the TATA Box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication J Virol 82 2008 849 858
123. S. Iyer, and B. Lonnerdal Lactoferrin, lactoferrin receptors and iron metabolism Eur J Clin Nutr 47 1993 232 241 (Pubitemid 23111661)
124. X.J. Jiang, B. Adler, K.L. Sampaio, M. Digel, G. Jahn, and N. Ettischer UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions J Virol 82 2008 2802 2812 (Pubitemid 351329171)
125. T. Jiang, H. Zhao, X.F. Li, Y.Q. Deng, J. Liu, and L.J. Xu CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model Antiviral Res 89 2011 124 126
126. J.Y. Jo, E. Gonzalez de Mejia, and M.A. Lila Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols J Agric Food Chem 54 2006 2083 2087
127. D.C. Johnson, and M.T. Huber Directed egress of animal viruses promotes cell-to-cell spread J Virol 76 2002 1 8 (Pubitemid 33138986)
128. R.A. Johnson, X. Wang, X.L. Ma, S.M. Huong, and E.S. Huang Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling J Virol 75 2001 6022 6032 (Pubitemid 32553133)
129. V. Joly, K. Jidar, M. Tatay, and P. Yeni Enfuvirtide: from basic investigations to current clinical use Expert Opin Pharmacother 11 2010 2701 2713
130. T.R. Jones, S.W. Lee, S.V. Johann, V. Razinkov, R.J. Visalli, and B. Feld Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule J Virol 78 2004 1289 1300 (Pubitemid 38095839)
131. V. Jovasevic, L. Liang, and B. Roizman Proteolytic cleavage of VP1-2 is required for release of herpes simplex virus 1 DNA into the nucleus J Virol 82 2008 3311 3319 (Pubitemid 351429909)
132. R.F. Kalejta Functions of human cytomegalovirus tegument proteins prior to immediate early gene expression Curr Top Microbiol Immunol 325 2008 101 115
133. R.F. Kalejta, and T. Shenk Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp 71 protein Proc Natl Acad Sci U S A 100 2003 3263 3268 (Pubitemid 36356571)
134. S. Kamstrup, T.H. Frimann, and A.M. Barfoed Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides Antiviral Res 72 2006 42 48 (Pubitemid 44308444)
135. K. Kanekiyo, J.B. Lee, K. Hayashi, H. Takenaka, Y. Hayakawa, and S. Endo Isolation of an antiviral polysaccharide, nostoflan, from a terrestrial cyanobacterium, Nostoc flagelliforme J Nat Prod 68 2005 1037 1041 (Pubitemid 41151758)
136. B. Kari, and R. Gehrz A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope J Virol 66 1992 1761 1764
137. B. Kari, and R. Gehrz Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II J Gen Virol 74 1993 255 264 (Pubitemid 23075354)
138. M. Kaspari, N. Tavalai, T. Stamminger, A. Zimmermann, R. Schilf, and E. Bogner Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus FEBS Lett 582 2008 666 672
139. M.J. Keller, D.G. Wheeler, E. Cooper, and J.L. Meier Role of the human cytomegalovirus major immediate-early promoter's 19-base-pair-repeat cyclic AMP-response element in acutely infected cells J Virol 77 2003 6666 6675 (Pubitemid 36666860)
140. A. Kenneson, and M.J. Cannon Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection Rev Med Virol 17 2007 253 276 (Pubitemid 47066638)
141. J.M. Kilby, S. Hopkins, T.M. Venetta, B. Di Massimo, G.A. Cloud, and J.Y. Lee Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry Nat Med 4 1998 1232 1233
142. D.W. Kimberlin, C.Y. Lin, P.J. Sanchez, G.J. Demmler, W. Dankner, and M. Shelton Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial J Pediatr 143 2003 16 25 (Pubitemid 36928564)
143. A.M. Krieg Therapeutic potential of Toll-like receptor 9 activation Nat Rev Drug Discov 6 2006 471 484 (Pubitemid 44136959)
144. M.E. Kuipers, H.G. de Vries-Hospers, M.C. Eikelboom, D.K.F. Meijer, and P.J. Swart Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates Antimicrob Agents Chemother 43 1999 2635 2641 (Pubitemid 29519541)
145. D.R. Kuritzkes HIV-1 entry inhibitors: an overview Curr Opin HIV AIDS 4 2009 82 87
146. S. Landolfo, M. Gariglio, G. Gribaudo, and D. Lembo The human cytomegalovirus Pharmacol Ther 98 2003 269 297 (Pubitemid 36638545)
147. P.E. Lashmit, C.A. Lundquist, J.L. Meier, and M.F. Stinski Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter J Virol 78 2004 5113 5123 (Pubitemid 38581463)
148. A.P. Lea, and H.M. Bryson Cidofovir Drugs 52 1996 225 230 (Pubitemid 26259619)
149. J.B. Lee, K. Hayashi, T. Hayashi, U. Sankawa, and M. Maeda Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum Planta Med 65 1999 439 441 (Pubitemid 29299835)
150. D. Lembo, M. Donalisio, M. Rusnati, A. Bugatti, M. Cornaglia, and P. Cappello Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus Antimicrob Agents Chemother 52 2008 1374 1381 (Pubitemid 351522001)
151. S. Leone, T. Cornetta, E. Basso, and R. Cozzi Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction Cancer Lett 295 2010 167 172
152. P.F. Levay, and M. Viljoen Lactoferrin: a general review Haematologica 80 1995 252 267
153. Y.Q. Li, Z.L. Li, W.J. Zhao, R.X. Wen, Q.W. Meng, and Y. Zeng Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication Eur J Med Chem 41 2006 1084 1089 (Pubitemid 44353865)
154. Y.M. Lin, M.T. Flavin, R. Schure, F.C. Chen, R. Sidwell, and D.L. Barnard Antiviral activities of biflavonoids Planta Med 65 1999 120 125 (Pubitemid 29138142)
155. U. Lindahl, K. Lidholt, D. Spillmann, and L. Kjellen More to "heparin" than anticoagulation Thromb Res 75 1994 1 32
156. U. Lindahl, M.K. Gullberg, and L. Kjellen Regulated diversity of heparan sulfate J Biol Chem 273 1998 24979 24982 (Pubitemid 28443251)
157. E. Littler, A.D. Stuart, and M.S. Chee Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir Nature 358 1992 160 162
158. B. Liu, and M.F. Stinski Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements J Virol 66 1992 4434 4444
159. M. Liuzzi, R. Deziel, N. Moss, P. Beaulieu, A.M. Bonneau, and C. Bousquet A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo Nature 372 1994 695 698
160. B. Lonnerdal, and S. Iyer Lactoferrin: molecular structure and biological function Annu Rev Nutr 15 1995 93 110
161. M. Lopper, and T. Compton Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion J Virol 78 2004 8333 8341 (Pubitemid 38944317)
162. A. Loregian, and D.M. Coen Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase Chem Biol 13 2006 191 200 (Pubitemid 43255591)
163. A. Loregian, and G. Palù Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy Clin Microbiol Infect 11 2005 437 446 (Pubitemid 40744390)
164. A. Loregian, and G. Palù Disruption of protein-protein interactions: towards new targets for chemotherapy J Cell Physiol 204 2005 750 762 (Pubitemid 41099260)
165. A. Loregian, E. Papini, B. Satin, H.S. Marsden, T.R. Hirst, and G. Palù Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin Proc Natl Acad Sci U S A 96 1999 5221 5226 (Pubitemid 29214564)
166. A. Loregian, H.S. Marsden, and G. Palù Protein-protein interactions as targets for antiviral chemotherapy Rev Med Virol 12 2002 239 262 (Pubitemid 34832160)
167. A. Loregian, R. Rigatti, M. Murphy, E. Schievano, G. Palù, and H.S. Marsden Inhibition of human cytomegalovirus (HCMV) DNA polymerase by C-terminal peptides from the UL54 subunit J Virol 77 2003 8336 8344 (Pubitemid 36871462)
168. A. Loregian, B. Mercorelli, G. Muratore, E. Sinigalia, S. Pagni, and S. Massari The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein Antimicrob Agents Chemother 54 2010 1930 1940
169. D. Lowance, H.H. Neumayer, C.M. Legendre, J.P. Squifflet, J. Kovarik, and P.J. Brennan Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group N Engl J Med 340 1999 1462 1470 (Pubitemid 29220545)
170. A. Luganini, P. Caposio, S. Landolfo, and G. Gribaudo Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry Antimicrob Agents Chemother 52 2008 1111 1120 (Pubitemid 351358395)
171. A. Luganini, P. Caposio, M. Mondini, S. Landolfo, and G. Gribaudo New cell-based indicator assays for the detection of human cytomegalovirus infection and screening of inhibitors of viral immediate-early 2 protein activity J Appl Microbiol 105 2008 1791 1801
172. A. Luganini, A. Giuliani, G. Pirri, L. Pizzuto, S. Landolfo, and G. Gribaudo Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate Antiviral Res 85 2010 532 540
173. D.M. Lukac, J.R. Manuppello, and J.C. Alwine Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex J Virol 68 1994 5184 5193 (Pubitemid 24226587)
174. D.M. Lukac, N.Y. Harel, N. Tanese, and J.C. Alwine TAF-like functions of human cytomegalovirus immediate-early proteins J Virol 71 1997 7227 7239 (Pubitemid 27391657)
175. V. Lukashchuk, S. McFarlane, R.D. Everett, and C.M. Preston Human cytomegalovirus protein pp 71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection J Virol 82 2008 12543 12554
176. A. Lupas Coiled coils: new structures and new functions Trends Biochem Sci 21 1996 375 382 (Pubitemid 26338674)
177. N.S. Lurain, and S. Chou Antiviral drug resistance of human cytomegalovirus Clin Microbiol Rev 23 2010 689 712
178. N.S. Lurain, L.E. Spafford, and K.D. Thompson Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir J Virol 68 1994 4427 4431 (Pubitemid 24183037)
179. A. Macagno, N.L. Bernasconi, F. Vanzetta, E. Dander, A. Sarasini, and M.G. Revello Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex J Virol 84 2010 1005 1013
180. M.P. Macias, L. Huang, P.E. Lashmit, and M.F. Stinski Cellular or viral protein binding to a cytomegalovirus promoter transcription initiation site: effects on transcription J Virol 70 1996 3628 3635 (Pubitemid 26157343)
181. P. Mandal, C.A. Pujol, M.J. Carlucci, K. Chattopadhyay, E.B. Damonte, and B. Ray Sulfated xylomannan of Scinaia hetai: isolation, structural features and antiviral activity Phytochemistry 69 2008 2193 2199
182. A. Marcello, A. Loregian, A. Cross, H.S. Marsden, T.R. Hirst, and G. Palù Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit Proc Natl Acad Sci U S A 91 1994 8994 8998
183. M. Marchetti, C. Longhi, M.P. Conte, S. Pisani, P. Valenti, and L. Seganti Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells Antiviral Res 29 1996 221 231 (Pubitemid 26135179)
184. A. Marchini, H. Liu, and H. Zhu Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes J Virol 75 2001 1870 1878 (Pubitemid 32110177)
185. A. Markham, and D. Faulds Ganciclovir. An update of its therapeutic use in cytomegalovirus infection Drugs 48 1994 455 484
186. J.L. Meier, and J.A. Pruessner The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression J Virol 74 2000 1602 1613 (Pubitemid 30434015)
187. J.L. Meier, M.J. Keller, and J.J. McCoy Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication J Virol 76 2002 313 326 (Pubitemid 33139016)
188. B. Mercorelli, E. Sinigalia, A. Loregian, and G. Palu Human cytomegalovirus DNA replication: antiviral targets and drugs Rev Med Virol 18 2008 177 210 (Pubitemid 351693495)
189. B. Mercorelli, G. Muratore, E. Sinigalia, O. Tabarrini, M.A. Biasolo, and V. Cecchetti A 6-aminoquinolone compound, WC5, with potent and selective anti-human cytomegalovirus activity Antimicrob Agents Chemother 53 2009 312 315
190. B. Mercorelli, P. Oreste, E. Sinigalia, G. Muratore, D. Lembo, and G. Palù Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus Antimicrob Agents Chemother 54 2010 4561 4567
191. M. Michaelis, C. Paulus, N. Loschmann, S. Dauth, E. Stange, and H.W. Doerr The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication Cell Mol Life Sci 68 2011 1079 1090
192. D. Mitrocotsa, S. Mitaku, S. Axarlis, C. Harvala, and M. Malamas Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus Planta Med 66 2000 377 379 (Pubitemid 30346309)
193. E.S. Mocarski, T. Shenk, and R.F. Pass Cytomegaloviruses D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus, Fields Virology 5th ed. 2007 Lippincott Williams & Wilkins 2701 2772
194. G.B. Mulamba, A. Hu, R.F. Azad, K.P. Anderson, and D.M. Coen Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922) Antimicrob Agents Chemother 42 1998 971 973 (Pubitemid 28216396)
195. T. Murayama, Y. Eizuru, R. Yamada, H. Sadanari, K. Matsubara, and G. Rukung Anticytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eckl. & Zeyh.) Antivir Chem Chemother 18 2007 133 139 (Pubitemid 47167765)
196. E. Murphy, D. Yu, J. Grimwood, J. Schmutz, M. Dickson, and M.A. Jarvis Coding potential of laboratory and clinical strains of human cytomegalovirus Proc Natl Acad Sci U S A 100 2003 14976 14981 (Pubitemid 37518002)
197. L. Naesens, and E. De Clercq Recent developments in herpesvirus therapy Herpes 8 2001 12 16 (Pubitemid 32290373)
198. J. Netterwald, S. Yang, W. Wang, S. Ghanny, M. Cody, and P. Soteropoulos Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication J Virol 79 2005 5035 5046 (Pubitemid 40464254)
199. M. Nevels, C. Paulus, and T. Shenk Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation Proc Natl Acad Sci U S A 101 2004 17234 17239 (Pubitemid 39627803)
200. J. Neyts, R. Snoeck, D. Schols, J. Balzarini, J.D. Esko, and A. Van Schepdael Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate Virology 189 1992 48 58
201. A. Nitzsche, C. Paulus, and M. Nevels Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells J Virol 82 2008 11167 11180
202. F. Nosten Artemisinin: large community studies Trans R Soc Trop Med Hyg 88 Suppl 1 1994 S45 S46
203. D.M. Nowlin, N.R. Cooper, and T. Compton Expression of a human cytomegalovirus receptor correlates with infectibility of cells J Virol 65 1991 3114 3121
204. K. Ogawa-Goto, K. Tanaka, W. Gibson, E. Moriishi, Y. Miura, and T. Kurata Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid J Virol 77 2003 8541 8547 (Pubitemid 36871482)
205. A.T. Palamara, L. Nencioni, K. Aquilano, G. De Chiara, L. Hernandez, and F. Cozzolino Inhibition of influenza A virus replication by resveratrol J Infect Dis 191 2005 1719 1729 (Pubitemid 40656761)
206. M. Paolini, A. Sapone, and L. Valgimigli Avoidance of bioflavonoid supplements during pregnancy: a pathway to infant leukemia? Mutat Res 527 2003 99 101 (Pubitemid 36638594)
207. G.S. Pari, A.K. Field, and J.A. Smith Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37 Antimicrob Agents Chemother 39 1995 1157 1161
208. J.J. Park, Y.E. Kim, H.T. Pham, E.T. Kim, Y.H. Chung, and J.H. Ahn Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts J Gen Virol 88 2007 3214 3223 (Pubitemid 350201830)
209. C. Parolin, B. Gatto, C. Del Vecchio, T. Pecere, E. Tramontano, and V. Cecchetti New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action Antimicrob Agents Chemother 47 2003 889 896 (Pubitemid 36254211)
210. D. Pasdeloup, D. Blondel, A.L. Isidro, and F.J. Rixon Herpesvirus capsid association with the nuclear pore complex and viral DNA release involve the nucleoporin CAN/Nup214 and the capsid protein pUL25 J Virol 83 2009 6610 6623
211. R.R. Penkert, and R.F. Kalejta Nuclear localization of tegument-delivered pp 71 in human cytomegalovirus-infected cells is facilitated by one or more factors present in terminally differentiated fibroblasts J Virol 84 2010 9853 9863
212. N. Perrimon, and M. Bernfield Specificities of heparan sulphate proteoglycans in developmental processes Nature 404 2000 725 728 (Pubitemid 30212391)
213. C.M. Perry, and J.A. Balfour Fomivirsen Drugs 57 1999 375 380
214. C.M. Perry, and D. Faulds Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections Drugs 52 1996 754 772 (Pubitemid 26382191)
215. D.T. Petrik, K.P. Schmitt, and M.F. Stinski The autoregulatory and transactivating functions of the human cytomegalovirus IE86 protein use independent mechanisms for promoter binding J Virol 81 2007 5807 5818 (Pubitemid 46847018)
216. B.D. Pilger, C. Cui, and D.M. Coen Identification of a small molecule that inhibits herpes simplex virus DNA polymerase subunit interactions and viral replication Chem Biol 11 2004 647 654 (Pubitemid 38708833)
217. D. Pinna, P. Oreste, T. Coradin, A. Kajaste-Rudnitski, S. Ghezzi, and G. Zappetti Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide Antimicrob Agents Chemother 52 2008 3078 3084
218. E. Poole, E. Atkins, T. Nakayama, O. Yoshie, I. Groves, and A. Alcami NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86 J Virol 82 2008 4250 4256 (Pubitemid 351563662)
219. S. Prosch, C. Priemer, C. Hoflich, C. Liebenthaf, N. Babel, and D.H. Kruger Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation Antivir Ther 8 2003 555 567 (Pubitemid 38057101)
220. P. Raanani, A. Gafter-Gvili, M. Paul, I. Ben-Bassat, L. Leibovici, and O. Shpilberg Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation Cochrane Database Syst Rev 8 2008 CD006501
221. K. Radtke, D. Kieneke, A. Wolfstein, K. Michael, W. Steffen, and T. Scholz Plus- and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures PLoS Pathog 6 2010 e1000991
222. P. Rathee, H. Chaudhary, S. Rathee, D. Rathee, V. Kumar, and K. Kohli Mechanism of action of flavonoids as anti-inflammatory agents: a review Inflamm Allergy Drug Targets 8 2009 229 235
223. R.R. Razonable, and V.C. Emery Management of CMV infection and disease in transplant patients Herpes 11 2004 77 86 (Pubitemid 40064892)
224. S. Rechter, T. Konig, S. Auerochs, S. Thulke, H. Walter, H. Dornenburg, C. Walter, and M. Marschall Antiviral activity of Arthrospira-derived spirulan-like substances Antiviral Res 72 2006 197 206 (Pubitemid 44708302)
225. M. Reeves, J. Murphy, R. Greaves, J. Fairley, A. Brehm, and J. Sinclair Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86 J Virol 80 2006 9998 10009 (Pubitemid 44522594)
226. M.G. Revello, and G. Gerna Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications Rev Med Virol 20 2010 136 155
227. M.G. Revello, E. Percivalle, E. Arbustivi, R. Pardi, S. Sozzoni, and G. Gerna In vitro generation of human cytomegalovirus pp 65 antigenemia, viremia, and leukoDNAemia J Clin Invest 101 1998 2686 2692 (Pubitemid 28294577)
228. V. Robin, A. Irurzun, M. Amoros, J. Boustie, and L. Carrasco Antipoliovirus flavonoids from Psiadia dentata Antivir Chem Chemother 12 2001 283 291 (Pubitemid 34168776)
229. P.J. Rosenthal Artesunate for the treatment of severe falciparum malaria N Engl J Med 358 2008 1829 1836
230. J.A. Ross Dietary flavonoids and the MLL gene: a pathway to infant leukemia? Proc Natl Acad Sci U S A 97 2000 4411 4413 (Pubitemid 30238565)
231. D.M. Roy, and J.E. Grundy Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations Transplantation 54 1992 1109 1110 (Pubitemid 23005557)
232. M. Rusnati, P. Oreste, G. Zappetti, and M. Presta Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery Curr Pharm Des 11 2005 2489 2499 (Pubitemid 40872693)
233. M. Rusnati, E. Vicenzi, M. Donalisio, P. Oreste, S. Landolfo, and D. Lembo Sulfated K5 Escherichia coli polysaccharide derivatives: a novel class of candidate antiviral microbicides Pharmacol Ther 123 2009 310 322
234. B.J. Ryckman, M.A. Jarvis, D.D. Drummond, J.A. Nelson, and D.C. Johnson Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion J Virol 80 2006 710 722 (Pubitemid 43062884)
235. B.J. Ryckman, B.L. Rainish, M.C. Chase, J.A. Borton, J.A. Nelson, and M.A. Jarvis Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells J Virol 82 2008 60 70 (Pubitemid 350309123)
236. E. Schlaepfer, A. Audige, B. von Beust, V. Manolova, M. Weber, and H. Joller CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo J Virol 78 2004 12344 12354 (Pubitemid 39458753)
237. M.R. Schleiss Comparison of vaccine strategies against congenital CMV infection in the guinea pig model J Clin Virol 41 2008 224 230 (Pubitemid 351232309)
238. R. Schwartz, M.H. Sommer, A. Scully, and D.H. Spector Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter J Virol 68 1994 5613 5622 (Pubitemid 24258574)
239. A.L. Scully, M.H. Sommer, R. Schwartz, and D.H. Spector The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations J Virol 69 1995 6533 6540
240. K. Sekiya, and H. Okuda Selective inhibition of platelet lipoxygenase by baicalein Biochem Biophys Res Commun 105 1982 1090 1095 (Pubitemid 13219433)
241. X. Shang, X. He, X. He, M. Li, R. Zhang, and P. Fan The genus Scutellaria an ethnopharmacological and phytochemical review J Ethnopharmacol 24 2010 279 313
242. K. Shimizu, H. Matsuzawa, K. Okada, S. Tazume, S. Dosako, and Y. Kawasaki Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity Arch Virol 141 1996 1875 1889 (Pubitemid 26392962)
243. B. Shogan, L. Kruse, G.B. Mulamba, A. Hu, and D.M. Coen Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B J Virol 80 2006 4740 4747
244. N. Singh Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy Rev Med Virol 16 2006 281 287 (Pubitemid 44497309)
245. C. Sinzger, M. Digel, and G. Jahn Cytomegalovirus cell tropism Curr Top Microbiol Immunol 325 2008 63 83
246. J.A. Smith, and G.S. Pari Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication J Virol 69 1995 1925 1931
247. R. Snoeck, G. Andrei, B. Bodaghi, L. Lagneaux, D. Daelemans, and E. de Clercq 2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections Antiviral Res 55 2002 413 424 (Pubitemid 35223097)
248. D.R. Snydman Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation Transpl Infect Dis 3 Suppl 2 2001 6 13 (Pubitemid 34073650)
249. D.R. Snydman The case for cytomegalovirus prophylaxis in solid organ transplantation Rev Med Virol 16 2006 289 295 (Pubitemid 44497310)
250. L. Soroceanu, A. Akhavan, and C.S. Cobbs Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection Nature 455 2008 391 395
251. C. Steininger, E. Puchhammer-Stockl, and T. Popow-Kraupp Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART) J Clin Virol 37 2006 1 9 (Pubitemid 44279524)
252. M.F. Stinski, and H. Isomura Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency Med Microbiol Immunol 197 2008 223 231
253. M.F. Stinski, and D.T. Petrik Functional roles of the human cytomegalovirus essential IE86 protein Curr Top Microbiol Immunol 325 2008 133 152
254. D.N. Streblow, J. Dumortier, A.V. Moses, S.L. Orloff, and J.A. Nelson Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing Curr Top Microbiol Immunol 325 2008 397 415
255. R. Strick, P.L. Strissel, S. Borgers, S.L. Smith, and J.D. Rowley Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia Proc Natl Acad Sci U S A 97 2000 4790 4795 (Pubitemid 30238636)
256. V. Sullivan, C.L. Talarico, S.C. Stanat, M. Davis, D.M. Coen, and K.K. Biron A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells Nature 358 1992 162 164
257. P.J. Swart, M.E. Kuipers, C. Smit, R. Pauwels, M.P. de Béthune, and E. De Clercq Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro AIDS Res Hum Retroviruses 12 1996 769 775 (Pubitemid 26171118)
258. P.J. Swart, M.C. Harmsen, M.E. Kuipers, A.A. Van Dijk, B.W.A. van der Strate, and P.H.C. Van Berkel Charge modification of plasma and milk proteins results in antiviral active compounds J Pept Sci 5 1999 563 576 (Pubitemid 30019138)
259. N. Tavalai, and T. Stamminger New insights into the role of the subnuclear structure ND10 for viral infection Biochim Biophys Acta 1783 2008 2207 2221
260. R.T. Taylor, and W.A. Bresnahan Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production J Virol 79 2005 3873 3877 (Pubitemid 40327977)
261. R.T. Taylor, and W.A. Bresnahan Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression J Virol 80 2006 10763 10771 (Pubitemid 44628922)
262. R.T. Taylor, and W.A. Bresnahan Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression J Virol 80 2006 920 928 (Pubitemid 43062904)
263. E. Trantas, N. Panopoulos, and F. Ververidis Metabolic engineering of the complete pathway leading to heterologous biosynthesis of various flavonoids and stilbenoids in Saccharomyces cerevisiae Metab Eng 11 2009 355 366
264. S. Tumova, A. Woods, and J.R. Couchman Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions Int J Biochem Cell Biol 32 2000 269 288 (Pubitemid 30069970)
265. J. Turnbull, A. Powell, and S. Guimond Heparan sulfate: decoding a dynamic multifunctional cell regulator Trends Cell Biol 11 2001 75 82 (Pubitemid 32144754)
266. H.A. Valantine, H. Luikart, R. Doyle, J. Theodore, S. Hunt, and P. Oyer Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone Transplantation 72 2001 1647 1652
267. P.H.C. van Berkel, M.E.J. Geerts, H.A. van Veen, M. Mericskay, H.A. de Boer, and J.H. Nuijens N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA Biochem J 328 1997 145 151 (Pubitemid 27499451)
268. A.N. van Den Pol, E. Mocarski, N. Saederup, J. Vieira, and T.J. Meier Cytomegalovirus cell tropism, replication, and gene transfer in brain J Neurosci 19 1999 10948 10965 (Pubitemid 30235739)
269. B.W. van der Strate, L. Beljaars, G. Molema, M.C. Harmsen, and D.K.F. Meijer Antiviral activities of lactoferrin Antiviral Res 52 2001 225 239 (Pubitemid 33000113)
270. B.W.A. van der Strate, M.C. Harmsen, P. Schafer, P.J. Swart, T.H. The, and G. Jahn Viral load in breast milk correlates with transmission of human cytomegalovirus to preterm neonates, but lactoferrin concentrations do not Clin Diagn Lab Immunol 8 2001 818 821 (Pubitemid 32613713)
271. B.W.A. van der Strate, F.M. De Boer, H.I. Bakker, D.K.F. Meijer, G. Molema, and M.C. Harmsen Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro Antiviral Res 58 2003 159 165 (Pubitemid 36559610)
272. E. Vicenzi, A. Gatti, S. Ghezzi, P. Oreste, G. Zoppetti, and G. Poli Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives AIDS 17 2003 177 181 (Pubitemid 36183042)
273. E.C. Villarreal Current and potential therapies for the treatment of herpes-virus infections Prog Drug Res 60 2003 263 307 (Pubitemid 36538118)
274. A.J. Wagstaff, and H.M. Bryson Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections Drugs 48 1994 199 226 (Pubitemid 24260355)
275. A.J. Wagstaff, D. Faulds, and K.L. Goa Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy Drugs 47 1994 153 205 (Pubitemid 24032382)
276. I. Waheed, C.J. Chiou, J.H. Ahn, and G.S. Hayward Binding of the human cytomegalovirus 80-kDa immediate-early protein (IE2) to minor groove A/T-rich sequences bounded by CG dinucleotides is regulated by protein oligomerization and phosphorylation Virology 252 1998 235 257 (Pubitemid 28564149)
277. D. Wang, and T. Shenk Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism Proc Natl Acad Sci U S A 102 2005 18153 18158 BIS (Pubitemid 41798517)
278. D. Wang, and T. Shenk Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism J Virol 79 2005 10330 10338 (Pubitemid 41098573)
279. X. Wang, S.M. Huong, M.L. Chiu, N. Raab-Traub, and E.S. Huang Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus Nature 424 2003 456 461 (Pubitemid 36917497)
280. F. Wei, S.C. Ma, L.Y. Ma, P.P. But, R.C. Lin, and I.A. Khan Antiviral flavonoids from the seeds of Aesculus chinensis J Nat Prod 67 2004 650 653 (Pubitemid 38533938)
281. C. Wellbrock, M. Karasarides, and R. Marais The RAF proteins take centre stage Nat Rev Mol Cell Biol 5 2004 875 885 (Pubitemid 39486539)
282. E.A. White, C.J. Del Rosario, R.L. Sanders, and D.H. Spector The IE2 60-kilodalton and 40-kilodalton proteins are dispensable for human cytomegalovirus replication but are required for efficient delayed early and late gene expression and production of infectious virus J Virol 81 2007 2573 2583 (Pubitemid 46447023)
283. M. Witvrouw, and E. De Clercq Sulfated polysaccharides extracted from sea algae as potential antiviral drugs Gen Pharmacol 29 1997 497 511 (Pubitemid 27421412)
284. J.P. Wong, L.P. Nagata, M.E. Christopher, A.M. Salazar, and R.M. Dale Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs Vaccine 23 2005 2266 2268 (Pubitemid 40341464)
285. D.L. Woodhall, I.J. Groves, M.B. Reeves, G. Wilkinson, and J.H. Sinclair Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter J Biol Chem 281 2006 37652 37660 (Pubitemid 46042068)
286. R. Yeh, and D.M. Coen Pharmacology of viral replication T.A.J. Golan DE, E.J. Armstrong, J.M. Galanter, A.W. Armstrong, R.A. Arnaout, H.S. Rose, Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy 2004 Lippincott, Williams & Wilkins Baltimore 545 564
287. L. Yi, Z. Li, K. Yuan, X. Qu, J. Chen, and G. Wang Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells J Virol 78 2004 11334 11339 (Pubitemid 39299674)